Continue to Site

Research & Development World

Home Page
Topics
- Aerospace
- Archeology
- Automotive
- Biotech
- Chemistry
- Environment
- Energy
- Life Science
- Material Science
- R&D Management
- Physics
Technology
R&D Market Pulse
2024 R&D 100 Awards
- Winner Archive
- R&D 100 Awards
Resources
- Digital Issues
- Podcasts
- Subscribe
- Video
- Webinars
Global Funding Forecast
R&D Index

Acadia Pharmaceuticals

By Acadia Pharmaceuticals | October 9, 2017

ACADIA Pharmaceuticals Initiates Phase III Study of Pimavanserin in Dementia-Related Psychosis

EXPAND YOUR KNOWLEDGE AND STAY CONNECTED

Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Connect with R&D World

Research & Development World

Subscribe to R&D World Magazine
Enews Sign Up
Contact Us
About Us
Drug Discovery & Development
Pharmaceutical Processing
2022 Global Funding Forecast

Copyright © 2024 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

Home Page
Topics
- Aerospace
- Archeology
- Automotive
- Biotech
- Chemistry
- Environment
- Energy
- Life Science
- Material Science
- R&D Management
- Physics
Technology
R&D Market Pulse
2024 R&D 100 Awards
- Winner Archive
- R&D 100 Awards
Resources
- Digital Issues
- Podcasts
- Subscribe
- Video
- Webinars
Global Funding Forecast
R&D Index